Investor mix
9 investors on record; lead investors include Frazier Life Sciences, Novartis Venture Fund.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 78% |
| Bank & private debt | 1 | 11% |
| Other / undisclosed | 1 | 11% |
Developer of therapeutics for patients with cancer and rare diseases
9 investors on record; lead investors include Frazier Life Sciences, Novartis Venture Fund.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 78% |
| Bank & private debt | 1 | 11% |
| Other / undisclosed | 1 | 11% |